Aveanna Healthcare Holdings Inc. (AVAH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$13.26 +1.53% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot)

Aveanna Healthcare Holdings Inc. (AVAH) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C β€’ HOLD / WATCH Cap $2.89B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH β€’ C
025507510065
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- Β· Rk D+
Cash (15)Whales (13)SEC (12)Macro (11)CEO (14)
Each axis scored 0–20
12M PRICE TARGET CONE+3.2% Base Target
$16 Bull$14 Base$11 Bear
πŸ“¬ FREE AVAH RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for AVAH)Realized 20D OHLCV Swing Band: Β±6.8%
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL β€’ FY 2025 (10-K)

How AVAH Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$125.9M (5.2% FCF Margin)
Revenue$2.43BGross Profit $810.5M (33.3%)Cost of Sales $1.62BOp Profit $256.5M (10.5%)OpEx (R&D/SG&A) $554.0MNet Profit$225.0K (0%)Tax/Other $256.2M

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

β–  Revenueβ–  Net Profitβ–  Free Cash Flow
FY23
Rev $1.90B
FY24
Rev $2.02B
FY25
Rev $2.43B
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$2.43B33.3%10.5%$225.0K$125.9M15.7%
FY 2024$2.02B31.4%6.9%-$10.9K$32.6M10.4%
FY 2023$1.90B33.3%0.4%-$134.5K$22.7M15.7%
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AVAH)

  • βœ“Walkthrough of AVAH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
AVAH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +102.75%β–² ASCENDING CHANNEL
2026-10-30O $13.39H $13.43L $12.96C $13.26VOL 1.34M
RES: $17.79SUP: $11.40SMA50: $13.10SMA200: $9.23
$15.30$12.87$10.45$8.02$5.60RES $17.79SUP $11.40$13.262026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AVAH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
12.8%/yr Implied 5Y Growth

vs. +20.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AVAH today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for AVAH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AVAH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AVAH)

1. Head-to-Head Health Care Peer Comparison (AVAH vs. PRVA, ADUS, WGS, OPCH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Aveanna Healthcare Holdings Inc. (AVAH) ranks #135 by composite RQD confidence (65/100, grade C) and #211 by equity capitalization ($2.89B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while AVAH leads on capital efficiency and profitability with 15.7% ROIC and 33.3% gross margin. OPCH currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with AVAH at 65/100 (C).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
AVAH ACTIVE
Aveanna Healthcare Holdings Inc.
C 65/100 β€” 33.3% 15.7% +1.53% $2.89B Benchmark Subject
PRVA
Privia Health Group Inc.
D+ 57/100 122.6x β€” 10.5% +0.71% $2.81B /prva-vs-avah β†’
ADUS
Addus HomeCare Corporation
C+ 69/100 24.2x 32.5% 9.1% +1.77% $2.32B /adus-vs-avah β†’
WGS
GeneDx Holdings Corp. (Class A)
D+ 58/100 β€” 69.7% -4.1% +9.79% $2.12B /wgs-vs-avah β†’
OPCH
Option Care Health Inc.
B 75/100 23.0x 19.3% 11.9% +1.79% $4.77B /opch-vs-avah β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2026-01-03 β€’ CIK 0001832332

In its most recent audited fiscal period (FY2025, filed 2026-01-03), Aveanna Healthcare Holdings Inc. (AVAH) reported GAAP revenue of $2.43B (+20.2% vs. FY2024 revenue of $2.02B , and +28.4% cumulative change since FY2023) , GAAP net income of $225.0K, operating cash flow of $125.9M, and free cash flow of $125.9M (+285.6% YoY). On the balance sheet, AVAH closed FY2025 with $2.01B in total assets against $1.29B in total debt (Altman Z-Score: 1.86, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-01-03 $2.43B $225.0K $125.9M $125.9M $2.01B $1.29B
FY2024 (FY) 2024-12-28 $2.02B -$10.9K $32.6M $32.6M $1.66B $1.27B
FY2023 (FY) 2023-12-30 $1.90B -$134.5K $22.7M $22.7M β€” β€”

3. AVAH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AVAH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 65/100 at a spot price of $13.26 (+1.53% 1D, market cap $2.89B). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, AVAH ranks #135 in composite RQD confidence.

How does AVAH compare to PRVA and ADUS in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), AVAH carries a Roarable C (65/100 RQD), trailing P/E of N/A, gross margin of 33.3%, and ROIC of 15.7%. By comparison, PRVA (Privia Health Group Inc.) holds a D+ grade (57/100 RQD, P/E 122.6x, ROIC 10.5%, cap $2.81B) and ADUS (Addus HomeCare Corporation) posts a C+ grade (69/100 RQD, P/E 24.2x, ROIC 9.1%, cap $2.32B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while AVAH leads on capital efficiency (15.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AVAH?

Per AVAH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0001832332), Aveanna Healthcare Holdings Inc. generated $2.43B in revenue (+20.2% YoY), $225.0K in net income, and $125.9M in free cash flow against $2.01B in total assets and $1.29B in total debt. Key quantitative strengths: Strong cash generator (33% profit margin)β€”profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AVAH trading relative to its 50-day, 200-day, and 52-week technical levels?

AVAH last traded at $13.26 (+1.53% on volume of 2,327,130 shares), positioning the stock +1.22% above its 50-day simple moving average ($13.10) and +43.66% above its 200-day simple moving average ($9.23). Across its 52-week range of $5.93 to $14.71, AVAH sits at the 83.5% percentile with a 14-day RSI of 56.0 (BULLISH MOMENTUM) and an implied next-earnings move of Β±6.8% ($12.36 to $14.16).

AVAH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

How profitable is Aveanna Healthcare Holdings Inc. (AVAH)?

In FY 2025 (10-K), AVAH converted $2.4B of revenue into a 33.3% gross margin, 10.5% operating margin, and $125.9M in free cash flow (5.2% FCF margin).

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%